Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Lavender Bina Cendikia Tbk. (BMBL) vs Merck Tbk. (MERK)

Lavender Bina Cendikia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Lavender Bina Cendikia Tbk. dan Merck Tbk.: Lavender Bina Cendikia Tbk. diperdagangkan di Rp32 (kapitalisasi pasar 32,96 M, volume 24 jam 500), sedangkan Merck Tbk. diperdagangkan di Rp3.930 (kapitalisasi pasar 1,75 T, volume 24 jam 300). Perbedaan utamanya: Merck Tbk. jauh lebih besar — sekitar 53,1× kapitalisasi pasar Lavender Bina Cendikia Tbk., dan Lavender Bina Cendikia Tbk. lebih aktif diperdagangkan (500 vs 300). Mana yang lebih baik tergantung tujuan investasimu.

BMBLMERK
Kapitalisasi Pasar
32,96 M1,75 T
Volume
500300
Lot
53
Perputaran
15,9 rb1,18 jt
Harga Rata-rata
31,83.930
Nilai Transaksi
15,9 rb1,18 jt
Harga Ekuilibrium Indikatif
3.930
Volume Ekuilibrium Indikatif
3

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

BMBL
Lihat detail
MERK
Lihat detail

Tentang Lavender Bina Cendikia Tbk.

PT Lavender Bina Cendikia Tbk ("Company") was established on November 27, 2013 based on theNotarial deed of Suparman Hasyim, S.H., No. 35. The Company started its commercial operations in2013. The ultimate beneficial owner of the Company is Galih Pandekar.

Selengkapnya di halaman BMBL

Tentang Merck Tbk.

PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.

Selengkapnya di halaman MERK